Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
14.30
-0.20
(-1.38%)
As of 10:25:51 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-65,590
-65,590
-164,850
-142,612
128,641
Investing Cash Flow
-199
-199
-293
-3,376
-708
Financing Cash Flow
21,396
21,396
23,676
-3,134
-3,045
End Cash Position
66,917
66,917
111,309
252,776
401,897
Capital Expenditure
-199
-199
-293
-3,376
-708
Issuance of Debt
25,000
25,000
27,282
--
--
Repurchase of Capital Stock
--
--
--
--
-180
Free Cash Flow
-65,789
-65,789
-165,143
-145,988
127,933
12/31/2021 - 2/28/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MVIR.ST Medivir AB (publ)
1.9000
-0.52%
NXTCL.ST NextCell Pharma AB
3.8200
+2.14%
EGTX.ST Egetis Therapeutics AB (publ)
4.9600
-2.17%
XBRANE.ST Xbrane Biopharma AB (publ)
0.1530
-0.91%
BIOVIC-B.ST Biovica International AB (publ)
1.9860
+10.33%
ISOFOL.ST Isofol Medical AB (publ)
1.6540
-0.96%
VICO.ST Vicore Pharma Holding AB (publ)
8.11
-1.58%
ACE.ST Ascelia Pharma AB (publ)
3.4500
-1.85%
ONCO.ST Oncopeptides AB (publ)
1.6220
-4.14%
CANTA.ST Cantargia AB (publ)
1.7080
-1.61%